Cabergoline and pulmonary hypertension Patient Reports February 12, 2012

Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.

Cabergoline Side Effects Report #4626909-1
Cabergoline side effect was reported by a Physician from on Mar 21, 2005. Female patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure acute, diarrhoea, dilatation atrial, hypertension, mitral valve incompetence, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5639309-2
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Feb 14, 2008. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic stenosis, left ventricular hypertrophy, pulmonary hypertension . Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE, SINEMET. Patient recovered.

Cabergoline Side Effects Report #4917899-2
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Feb 06, 2006. Female patient, 69 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, mitral valve incompetence, nightmare, pulmonary hypertension , tricuspid valve incompetence, visual disturbance. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with ZOLOFT, MADOPARK, TOLTERODINE TARTRATE. Patient recovered.


Cabergoline Side Effects Report #5472014-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease , blood cholesterol increased, dyspnoea, gastrointestinal disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, pulmonary fibrosis , pulmonary hypertension . Cabergoline dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BUMETANIDE, OMEPRAZOLE, TRIHEXYPHENIDYL. Patient recovered.

Cabergoline Side Effects Report #5474726-5
Cabergoline side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 14, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, pulmonary fibrosis , pulmonary hypertension . Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D) ORAL. Patient recovered.

Cabergoline Side Effects Report #5086014-X
Cabergoline side effect was reported by a Pharmacist from SPAIN on Aug 07, 2006. Female patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: 4 MG (1 MG), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA, BENSERAZIDE, CARBIDOPA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4765597-0
Cabergoline side effect was reported by a Physician from SPAIN on Aug 24, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 6 MG (DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET, STALEVO, BESITRAN. Patient recovered.

Cabergoline Side Effects Report #4850529-7
Cabergoline side effect was reported by a Physician from SPAIN on Nov 30, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood lactate dehydrogenase increased, cardiomegaly, haemoptysis, mitral valve incompetence, nasopharyngitis, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with AMANTADINE, DILUTOL, MOTILIUM, SINEMET, STALEVO, BESITRAN. Patient recovered.


Cabergoline Side Effects Report #5165034-0
Cabergoline side effect was reported by a Physician from GERMANY on Nov 14, 2006. Male patient, 45 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, pulmonary hypertension , tricuspid valve incompetence, ventricular hypertrophy. Cabergoline dosage: 6 MG (1 D); ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE, MADOPAR. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4674025-5
Cabergoline side effect was reported by a Health Professional from on May 12, 2005. Female patient, 44 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 4 M G (4 MG, DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET CR. Patient recovered.

Cabergoline Side Effects Report #5605260-7
Cabergoline side effect was reported by a Health Professional from SWEDEN on Jan 21, 2008. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: confusional state, dilatation atrial, hallucination, heart valve incompetence, orthostatic hypotension, pulmonary hypertension , syncope. Cabergoline dosage: DAILY DOSE:8MG. During the same period patient was treated with ARICEPT, EMCONCOR, MADOPARK, MADOPARK QUICK, EXELON, EDRONAX, CIPRAMIL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #6104206-5
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #6115183-5
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #6121725-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #6124995-3
Cabergoline side effect was reported by a Physician from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #6115216-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 02, 2009. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary hypertension . Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE, RASAGILINE. Patient recovered.